Tag Archives: National Center for Global Health

Researchers at the National Center for Global Health, Italy recently described a novel biotechnological platform for the production of unrestricted cytotoxic T lymphocyte (CTL) vaccines. It relies on in vivo engineering of exosomes, i.e., nanovesicles constitutively released by all cells, ...

Exosomes are 50-150 nm sized nanovesicles released by all eukaryotic cells. Researchers at the National Center for Global Health, Italy very recently described a method to engineer exosomes in vivo with the E7 protein of Human Papilloma Virus (HPV). This ...